Bacil Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 ,inter alia, to consider and approve Intimation of Board Meeting to ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bacil Pharma has informed BSE that its Board of Directors will meet on Tuesday, 12 August 2025. The main agenda is to consider and approve the Unaudited Financial Results for the quarter ended 30 June 2025 (Q1 FY26). The Board will also discuss the resignation of Manager Mr. Ganpat Dhondu Salekar. Any other business may be taken up with the Chairperson's permission. The intimation is filed under Regulation 29 of SEBI's LODR Regulations, 2015.
This is a routine advance notice of a quarterly results board meeting — no direct impact on shareholders yet. Investors should watch the Q1 FY26 results announcement for actual financial performance. The Manager's resignation is a minor management-level change worth noting but not typically price-moving.